Erratum to:Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

查看全文 作　　者：Helin [1]Wang;Qi [1]Lu;Yifan [1]Miao;Jiaxuan [1]Song;Mingyang [1]Zhang;Haotian [2]Zhang;Zhonggui [1]He;Zixuan [1]Wang;Chutong [1]Tian;Jin [1]Sun 机构地区：[1]Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China;[2]School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University,Shenyang 110016,China 出　　处：《Nano Research》索引2023年第16卷第4期,共2页 基　　金：Address correspondence to:Chutong Tian,tianct_spu@126.com;Address correspondence to:Jin Sun,sunjin@syphu.edu.cn。 摘　　要：Erratum to Nano Research 2022,15(10):9092-9104 http://gffzzd3cc09b8251d45dfsqpxbx0co99666b9x.ffgz.tsg.suse.edu.cn/10.1007/s12274-022-4544-7 Figure 9 was unfortunately mistakenly typeset.This error did not affect any of the conclusions from the published paper. 关 键 词：chemotherapy FIGURE COMBINE